HCEG Healthcare Ent.

RNS Number:1906Z
Healthcare Enterprise Group PLC
28 June 2007

28 June 2007

Healthcare Enterprise Group PLC

Transfer of Ebiox Distribution Agreement to Dentsply


Healthcare Enterprise Group PLC ("HCEG", AIM: HCEG) announces that the contract
between its wholly owned subsidiary Ebiox Limited and Sultan Healthcare Inc. 
("Sultan") will transfer to Dentsply International Inc. ("Dentsply", NYSE:XRAY),
along with the purchase obligations, following completion of the purchase of
Sultan by Dentsply, one of the largest professional dental products companies in
the world.


The contract which HCEG announced in January 2007, is for the for the exclusive
distribution of Ebiox product to the dental market in UK, continental Europe,
Latin America, South America, Asia and Africa.  The agreement is for an initial
term of five years and requires a minimum purchase of US$4.5 million (#2.33
million) of Ebiox products over that time.


The acquisition of Sultan by Dentsply which was announced to the New York Stock
Exchange on 21 June 2007, is expected to close in July 2007.


Lyndon Gaborit, HCEG Executive Deputy Chairman commented:


"We believe that this is a very positive development for HCEG.  Dentsply has a
major global distribution network and strong presence worldwide, including the
EU and UK, which could bring a step change to the distribution of Ebiox.  We
look forward to working with Dentsply in their efforts to grow in the area of
infection control."


Enquiries:


Healthcare Enterprise Group                              +44 (0)1925 898 200
Lyndon Gaborit, Executive Deputy Chairman


College Hill                                             +44 (0) 20 7457 2020
Adrian Duffield / Corinna Dorward

Notes

Healthcare Enterprise Group PLC (www.hcegroup.com)



HCEG is a business engaged in medical product distribution, occupational health,
and first aid markets.  These businesses underpin a range of innovative medical
devices. HCEG is listed on the Alternative Investment Market (AIM) of the London
Stock Exchange.

Ebiox (www.ebiox.com)

Patented decontamination and disinfectant products that are safe and alcohol
free but substantially more effective than conventional methods at destroying
embedded microorganisms.  The Ebiox range includes hand hygiene products,
surface disinfectants, products to clean and decontaminate surgical instruments,
and dental cleaning products.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGRVVLBLDQBFBBV

Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jun 2024 to Jul 2024

Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jul 2023 to Jul 2024